Management of Opioid-Induced Constipation in Cancer Patients: Focus on Methylnaltrexone

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.5, 2012-05, pp. : 293-301

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylnaltrexone for opioid-induced constipation

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Methylnaltrexone for opioid-induced constipation

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Methylnaltrexone: relieving opioid-induced constipation

Reactions Weekly, Vol. 1, Iss. 1107, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Methylnaltrexone: relieving opioid-induced constipation

Inpharma, Vol. 1, Iss. 1543, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Methylnaltrexone: the answer to opioid-induced constipation?

By Cannom Rebecca R Mason Rodney J

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 1039-1045

Informa Healthcare

Access to resources Recommend Favorite